Billiontoone (NASDAQ:BLLN) Shares Gap Down After Insider Selling

Billiontoone, Inc. (NASDAQ:BLLN)’s share price gapped down before the market opened on Thursday after an insider sold shares in the company. The stock had previously closed at $113.89, but opened at $101.40. Billiontoone shares last traded at $107.2220, with a volume of 305,885 shares traded.

Specifically, CTO David Tsao sold 20,000 shares of the stock in a transaction on Monday, November 2nd. The shares were sold at an average price of $109.24, for a total transaction of $2,184,800.00. Following the completion of the transaction, the chief technology officer owned 1,000 shares in the company, valued at approximately $109,240. This represents a 95.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 5,334 shares of Billiontoone stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $113.17, for a total value of $603,648.78. Following the completion of the sale, the chief executive officer directly owned 141,167 shares in the company, valued at approximately $15,975,869.39. This represents a 3.64% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In related news, CEO Oguzhan Atay sold 25,001 shares of the company’s stock in a transaction dated Monday, November 2nd. The stock was sold at an average price of $109.24, for a total transaction of $2,731,109.24. Following the sale, the chief executive officer owned 16,667 shares in the company, valued at approximately $1,820,703.08. This represents a 60.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Canaccord Genuity Group began coverage on Billiontoone in a research report on Wednesday, September 2nd. They set a “buy” rating and a $120.00 price target on the stock. Zacks Research raised Billiontoone from a “strong sell” rating to a “hold” rating in a report on Friday, October 2nd. Weiss Ratings cut shares of Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research note on Thursday, October 8th. Guggenheim boosted their target price on shares of Billiontoone from $125.00 to $128.00 and gave the stock a “buy” rating in a report on Thursday, October 1st. Finally, BTIG Research reaffirmed a “buy” rating and set a $130.00 price target on shares of Billiontoone in a research report on Thursday. Seven analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $126.25.

More Billiontoone News

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Q3 beat estimates: Revenue was approximately $123.0 million, above the $115.8 million FactSet estimate. Earnings also topped the $0.16-per-share consensus, though reports cite differing actual EPS figures. BillionToOne Q3 results and guidance
• Positive Sentiment: 2026 outlook raised: BillionToOne increased its full-year revenue forecast to $460 million–$470 million, signaling stronger expected growth. Revenue outlook and Northstar Clear news
• Positive Sentiment: New product planned: The company said it plans to launch Northstar Clear on December 15, offering a potential additional growth catalyst. Northstar Clear launch news
• Positive Sentiment: Buy rating reaffirmed: BTIG Research maintained its “buy” rating and a $130 price target, about 14% above the cited $113.89 share price. BTIG Research recommendations
• Negative Sentiment: Executives reported stock sales: The CEO, CTO and an SVP sold shares. The transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen—but do not remove—investor concern about insider selling. BillionToOne insider transaction report

Billiontoone Stock Performance

The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. The stock’s 50-day simple moving average is $104.67 and its 200 day simple moving average is $96.89. The stock has a market capitalization of $5.10 billion and a P/E ratio of 155.77.

Billiontoone (NASDAQ:BLLN) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting the consensus estimate of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The firm had revenue of $109.45 million for the quarter. Research analysts expect that Billiontoone, Inc. will post 0.80 EPS for the current fiscal year.

Hedge Funds Weigh In On Billiontoone

Large investors have recently made changes to their positions in the company. Wasatch Advisors LP grew its position in Billiontoone by 40.2% during the second quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after buying an additional 148,446 shares in the last quarter. Renaissance Technologies LLC acquired a new position in Billiontoone in the 1st quarter valued at $4,046,000. Emerald Advisers LLC lifted its position in shares of Billiontoone by 26.8% during the 1st quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock valued at $18,911,000 after acquiring an additional 50,613 shares during the period. Public Employees Retirement System of Ohio acquired a new stake in shares of Billiontoone during the 1st quarter worth $1,539,000. Finally, Perceptive Advisors LLC increased its position in shares of Billiontoone by 26.1% in the first quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock worth $7,248,000 after purchasing an additional 19,000 shares during the period.

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops tests designed to provide more sensitive and quantitative genetic information from blood samples. The company’s technology is based on its proprietary Quantitative Counting Template (QCT) platform, which is designed to measure DNA molecules with high sensitivity and support the detection of clinically meaningful genetic signals.

The company’s products include prenatal diagnostic and screening solutions marketed under the UNITY brand.